BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) announced that has completed the last on-treatment visit in its Phase 2 ADDRESS-LC clinical trial evaluating bezisterim in adults with Long COVID, with topline results targeted for release before the end of September 2026.
The Carson City, Nevada-based clinical-stage company is developing therapies for neurological and neurodegenerative diseases. The ADDRESS-LC study is evaluating whether bezisterim can improve neurological symptoms associated with Long COVID, including cognitive impairment and fatigue.
Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF, FRA:A6Y0) announced that it has completed drilling the 183-H2 well at its 100%-owned Murucututu natural gas field in Brazil.
The well reached a total measured depth of 3,176.5 metres and was drilled within an area assigned prospective resources by independent reserve evaluator GLJ.
TNR Gold Corp (TSX-V:TNR, FRA:TNW, OTC:TRRXF) has launched its 2026 exploration program at the Shotgun Gold Project in southwestern Alaska, advancing work at the Shotgun and Winchester prospects in the Taylor Mountain Quadrangle.
The program builds on 2022 fieldwork and will follow up on geochemical anomalies identified through Novagold Resources' 1998 soil surveys, along with geophysical targets flagged by SJ Geophysics' 2011 and 2012 IP surveys.
Arizona Gold & Silver Inc (TSX-V:AZS, OTCQB:AZASF, FRA:A9J0) has named Yale Simpson to its board as an independent director, effective immediately, expanding a role he had already held informally as a company advisor.
A geologist and entrepreneur with roughly 40 years in the mining industry, Simpson has worked across Australia, Africa, Eastern Europe and South America, focusing on resource strategy, financing and investor communications. He previously co-founded and chaired Exeter Resource Corporation, later bought by Goldcorp (now Newmont), and Extorre Resources, later bought by Yamana Gold (TSX:YRI, LSE:AUY) (now Pan American Silver).
Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF, FRA:1SS) reported a 101% year-over-year jump in first-quarter revenue, driven by growth in its event technology platform and a newly expanded services business.
Revenue for the quarter ended June 30, 2026 rose to $660,159 from $328,092 a year earlier, the company said.
Royal Road Minerals Ltd (TSX-V:RYR, OTC:RRDMF, FRA:RLU) announced plans to raise up to C$1 million, with proceeds going toward expanding its drilling programs in Colombia.
In a statement, the company said that strong investor demand prompted an existing institutional shareholder to buy in on the same terms as the company's recent brokered financing.
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has received a $700,000 Research and Development Tax Incentive rebate for the 2026 financial year, providing additional funding for the clinical development of its lead oncology asset HMBD-002.
The rebate relates to eligible research and development expenditure undertaken in Australia and overseas, with the proceeds to be directed toward Percheron’s clinical development plans.
archTIS Ltd (ASX:AR9, OTCQB:ARHLF) has submitted an updated licensing proposal to the United States Department of Defense (DoD), indicating potential annual revenue of between A$7.5 million and A$15 million under a one-year agreement.
The data security software provider was formally requested to prepare tiered pricing covering between 121,000 and 325,000 users, along with single and multi-year contract options, following executive briefings in Washington DC.